propionylcarnitine has been researched along with Inflammatory Bowel Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arena, V; Cittadini, A; Fiore, F; Franceschi, F; Gasbarrini, A; Gasbarrini, G; Laterza, L; Merra, G; Pizzoferrato, M; Poscia, A; Scaldaferri, F; Sgambato, A | 1 |
1 other study(ies) available for propionylcarnitine and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Carnitine; Female; Humans; Inflammatory Bowel Diseases; Male; Middle Aged; Prospective Studies | 2012 |